1. Academic Validation
  2. Familial manganese-induced neurotoxicity due to mutations in SLC30A10 or SLC39A14

Familial manganese-induced neurotoxicity due to mutations in SLC30A10 or SLC39A14

  • Neurotoxicology. 2018 Jan;64:278-283. doi: 10.1016/j.neuro.2017.07.030.
Somshuvra Mukhopadhyay 1
Affiliations

Affiliation

  • 1 Division of Pharmacology & Toxicology, College of Pharmacy, Institute for Cellular & Molecular Biology, Institute for Neuroscience, The University of Texas at Austin, 3.510E BME, 107 W. Dean Keeton, Austin, TX 78712, USA. Electronic address: [email protected].
Abstract

Over the last few years, two rare, familial diseases that lead to the onset of manganese (Mn)-induced neurotoxicity have been discovered. Loss-of-function mutations in SLC30A10, a Mn efflux transporter, or SLC39A14, a Mn influx transporter, increase Mn levels in blood and brain, and induce severe neurotoxicity. The discoveries of these genetic diseases have transformed our understanding of Mn homeostasis, detoxification, and neurotoxicity. Current knowledge about the mechanisms by which mutations in these transporters alter Mn homeostasis to induce human disease is reviewed here.

Keywords

Manganese neurotoxicity; Metal homeostasis; Parkinsonism; SLC30A10; SLC39A14; ZIP14; ZnT10.

Figures